Nature Reviews Cardiology

Papers
(The H4-Index of Nature Reviews Cardiology is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
LIPC variant in combined hypocholesterolaemia939
Antibody treatment to deplete transthyretin amyloid deposits in the heart457
Sacubitril–valsartan shows benefit in heart failure with ejection fraction of >40%455
Intravascular imaging improves outcomes403
Bariatric metabolic surgery more effective than GLP1R agonists in preventing congestive HF398
Accelerated reduction in global cardiovascular disease is essential to achieve the Sustainable Development Goals394
Genetics and mechanisms of thoracic aortic disease377
Aggregation of big tau disrupts microtubules and causes diastolic dysfunction368
Optimizing cardiovascular pharmacotherapy in older adults with frailty308
The City Heartbeat Index as a benchmarking tool for urban cardiovascular health302
Screening for Helicobacter pylori infection in patients with cardiovascular and gastrointestinal disease299
Takotsubo syndrome: pathophysiological insights and innovations in patient care297
Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults288
Alternative defibrillation strategies improve outcomes262
Think Aorta: aortic dissection awareness and perspectives from the patient247
Detection of subclinical hypertrophic cardiomyopathy247
HFpEF and MASLD: converging mechanisms and clinical implications237
Maternal cardiovascular disorders before and during pregnancy and offspring cardiovascular risk across the life course232
Drug-coated balloon angioplasty for coronary and peripheral artery disease: latest evidence and clinical indications226
Defining iron deficiency in patients with heart failure226
Base editing and silencing of PCSK9 shows clinical promise in humans225
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice223
Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale219
A fatty acid from mother’s milk drives cardiomyocyte maturation in newborn mice203
Hallmarks of cardiovascular ageing203
Preparticipation screening reduces SCD in young athletes195
Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes163
No benefit of apoA-I infusion after myocardial infarction159
Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular risk156
Catheter ablation improves outcomes in patients with AF and end-stage HF153
Colchicine in acute coronary syndromes: the present and the possible future146
Increased degradation of desmosomal proteins in ACM139
CSDE1 regulates LDL receptor levels137
Cardiac lymphatic dysfunction and repair in cardiovascular disease136
LDL-cholesterol lowering with obicetrapib129
Targeting immune cell recruitment in atherosclerosis128
Reactive oxygen species in hypertension124
Tailored therapeutics for cardiomyopathies124
Decongestion in heart failure: medical and device therapies122
The oral microbiome in the pathophysiology of cardiovascular disease121
Extracellular matrix in vascular homeostasis and disease121
Graded exercise therapy should not be recommended for patients with post-exertional malaise113
Modelling pre-eclampsia and its cardiovascular effects111
Donor macrophages influence rejection of transplanted hearts111
Cardiac sarcomere turnover by unidirectional replacement of proteins109
Reply to ‘Graded exercise therapy should not be recommended for patients with post-exertional malaise’109
Unlocking excellence in health care: the power of inclusive and sensitive language in medicine106
Bempedoic acid prevents cardiovascular events in statin-intolerant patients106
Promising novel siRNA for the treatment of hypertension104
Semaglutide is beneficial in patients with HFpEF and obesity102
Calculation methods for LDL cholesterol are evolving tools for accuracy in lipidology100
RNA interference lowers triglyceride levels99
Evidence does not support the reduction of added sugar intake from all food sources97
Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials96
Local calcium dynamics and signalling in cardiomyocytes95
Global epidemiology of heart failure94
An epigenome editing approach induces durable silencing of Pcsk992
Single-cell profiles of CHD and CM91
BP management with a village-doctor-led strategy88
Computational modelling of cardiovascular pathophysiology to risk stratify commercial spaceflight86
Simvastatin protects against endothelial dysfunction via epigenetic mechanisms84
The role of the molecular autopsy in sudden cardiac death in young individuals83
Author Correction: The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis81
Development of a miniature, bioresorbable, light-activated pacemaker77
The gut metabolite imidazole propionate is a potential biomarker of and therapeutic target for atherosclerosis76
Tricuspid valve disease: updates on diagnostic imaging and intervention73
Heart transplantation: advances in expanding the donor pool and xenotransplantation70
Efferocytosis in atherosclerosis70
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology69
Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target69
0.094019174575806